Koji Kuroda

Kitakyushu, 8078556, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications

Lessons from surgery after neoadjuvant chemoimmunotherapy for bulky, invasive N2 lung cancer: a case report.

Lessons from surgery after neoadjuvant chemoimmunotherapy for bulky, invasive N2 lung cancer: a case report.

Journal: General thoracic and cardiovascular surgery cases
Published: July 05, 2026

Successful Identification and Closure of an Occult Pleuroperitoneal Communication Using Intraoperative Indocyanine Green Fluorescence in a Patient Undergoing Peritoneal Dialysis: A Case Report.

Successful Identification and Closure of an Occult Pleuroperitoneal Communication Using Intraoperative Indocyanine Green Fluorescence in a Patient Undergoing Peritoneal Dialysis: A Case Report.

Journal: Cureus
Published: May 20, 2026

Stratification of Prognosis in Pulmonary Pleomorphic Carcinoma Based on Integrated PD-L1 and Multiparametric Biomarker Analysis.

Stratification of Prognosis in Pulmonary Pleomorphic Carcinoma Based on Integrated PD-L1 and Multiparametric Biomarker Analysis.

Journal: Cancers
Published: May 12, 2026

Impact of CD73/CD155 Expression on Survival in Resected Epithelial Pleural Mesothelioma: A Retrospective Single-center Study.

Impact of CD73/CD155 Expression on Survival in Resected Epithelial Pleural Mesothelioma: A Retrospective Single-center Study.

Journal: In vivo (Athens, Greece)
Published: March 04, 2026

Robotic Versus Video-Assisted Thoracoscopic Lobectomy/Segmentectomy: Multilevel Analysis in Japan.

Robotic Versus Video-Assisted Thoracoscopic Lobectomy/Segmentectomy: Multilevel Analysis in Japan.

Journal: Interdisciplinary cardiovascular and thoracic surgery
Published: November 09, 2025

PD-L1 expression as a prognostic factor for postoperative outcomes in pleural mesothelioma.

PD-L1 expression as a prognostic factor for postoperative outcomes in pleural mesothelioma.

Journal: Translational lung cancer research
Published: May 25, 2025

Real-world insights into atezolizumab plus bevacizumab, carboplatin, and paclitaxel for advanced non-squamous non-small cell lung cancer.

Real-world insights into atezolizumab plus bevacizumab, carboplatin, and paclitaxel for advanced non-squamous non-small cell lung cancer.

Journal: Translational lung cancer research
Published: April 28, 2025

Establishing a Highly Accurate Circulating Tumor Cell Image Recognition System for Human Lung Cancer by Pre-Training on Lung Cancer Cell Lines.

Establishing a Highly Accurate Circulating Tumor Cell Image Recognition System for Human Lung Cancer by Pre-Training on Lung Cancer Cell Lines.

Journal: Cancers
Published: April 19, 2025

Pemetrexed plus platinum as second-line treatment for patients with pleural mesothelioma treated with nivolumab plus ipilimumab.

Pemetrexed plus platinum as second-line treatment for patients with pleural mesothelioma treated with nivolumab plus ipilimumab.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 24, 2025

Predictors of successful closure following open-window thoracostomy in patients with empyema: a single-center retrospective cohort study.

Predictors of successful closure following open-window thoracostomy in patients with empyema: a single-center retrospective cohort study.

Journal: Journal of thoracic disease
Published: November 08, 2024

Surgical indications for pleurectomy/decortication in pleural mesothelioma based on the newly revised 9th edition of the tumour-node-metastasis classification.

Surgical indications for pleurectomy/decortication in pleural mesothelioma based on the newly revised 9th edition of the tumour-node-metastasis classification.

Journal: Interdisciplinary cardiovascular and thoracic surgery
Published: October 21, 2024

Target sequence of single cells captured by a polymeric microfluidic device.

Target sequence of single cells captured by a polymeric microfluidic device.

Journal: Scientific reports
Published: September 28, 2024
Showing 1-12 of 86

Last Updated: 09/26/2026